Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 30, 2008
Journal of the American Society of Nephrology
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2005111155
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2005111155v1
19/2/217    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, T.
Right arrow Articles by Nitta, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, T.
Right arrow Articles by Nitta, K.

Received November 4, 2005
Accepted on August 3, 2007

BASIC RESEARCH

ATF3 Protects against Renal Ischemia-Reperfusion Injury

Takumi Yoshida *{dagger}1, Hidekazu Sugiura *, Michihiro Mitobe *, Ken Tsuchiya *, Satsuki Shirota *, Sayoko Nishimura *, Shunji Shiohira *, Hiroshi Ito {ddagger}, Kiyoshi Nobori {sect}, Steven R. Gullans ||, Takashi Akiba *{dagger}, and Kosaku Nitta *

*Department of Medicine IV and {dagger}Department of Blood Purification, Tokyo Women’s Medical University, Tokyo, Japan; {ddagger}Division of Cardiovascular Medicine, Akita University School of Medicine Akita, Japan; {sect}Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan; ||Renal Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Cambridge, Massachusetts


1 To whom correspondence should be addressed. E-mail: tyoshida{at}kc.twmu.ac.jp.


   Abstract

Oxidative stress-induced cell death plays a major role in the progression of ischemic acute renal failure. Using microarrays, we sought to identify a stress-induced gene that may be a therapeutic candidate. Human proximal tubule (HK2) cells were treated with hydrogen peroxide (H2O2) and RNA was applied to an Affymetrix gene chip. Five genes were markedly induced in a parallel time-dependent manner by cluster analysis, including activating transcription factor 3 (ATF3), p21WAF1/CiP1 (p21), CHOP/GADD153, dual-specificity protein phosphatase, and heme oxygenase-1. H2O2 rapidly induced ATF3 approximately 12-fold in HK2 cells and approximately 6.5-fold in a mouse model of renal ischemia-reperfusion injury. Adenovirus-mediated expression of ATF3 protected HK2 cells against H2O2-induced cell death, and this was associated with a decrease of p53 mRNA and an increase of p21 mRNA. Moreover, when ATF3 was overexpressed in mice via adenovirus-mediated gene transfer, ischemia-reperfusion injury was reduced. In conclusion, ATF3 plays a protective role in renal ischemia-reperfusion injury and the mechanism of the protection may involve suppression of p53 and induction of p21.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP